MEDIROM Healthcare Technologies (MRM) Competitors $2.76 +1.56 (+130.00%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.67 -0.09 (-3.41%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRM vs. CHGG, HCMA, STG, YSXT, NAMI, BEDU, KUKE, AACG, KIDZ, and FEDUShould you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include Chegg (CHGG), HCM Acquisition (HCMA), Sunlands Technology Group (STG), YSX Tech (YSXT), NAMI (NAMI), Bright Scholar Education (BEDU), Kuke Music (KUKE), ATA (AACG), Classover (KIDZ), and Four Seasons Education (Cayman) (FEDU). These companies are all part of the "personal services" industry. MEDIROM Healthcare Technologies vs. Its Competitors Chegg HCM Acquisition Sunlands Technology Group YSX Tech NAMI Bright Scholar Education Kuke Music ATA Classover Four Seasons Education (Cayman) Chegg (NYSE:CHGG) and MEDIROM Healthcare Technologies (NYSE:MRM) are both small-cap personal services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability. Which has more risk & volatility, CHGG or MRM? Chegg has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500. Comparatively, MEDIROM Healthcare Technologies has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Is CHGG or MRM more profitable? MEDIROM Healthcare Technologies has a net margin of 0.00% compared to Chegg's net margin of -53.67%. MEDIROM Healthcare Technologies' return on equity of 0.00% beat Chegg's return on equity.Company Net Margins Return on Equity Return on Assets Chegg-53.67% -11.82% -2.88% MEDIROM Healthcare Technologies N/A N/A N/A Which has stronger earnings and valuation, CHGG or MRM? MEDIROM Healthcare Technologies has higher revenue and earnings than Chegg. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChegg$617.57M0.20-$837.07M-$2.61-0.44MEDIROM Healthcare Technologies$8.30B0.01$820KN/AN/A Do analysts recommend CHGG or MRM? Chegg presently has a consensus target price of $1.70, suggesting a potential upside of 49.14%. Given Chegg's higher probable upside, analysts plainly believe Chegg is more favorable than MEDIROM Healthcare Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chegg 3 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.57MEDIROM Healthcare Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Do insiders and institutionals hold more shares of CHGG or MRM? 95.2% of Chegg shares are held by institutional investors. 3.7% of Chegg shares are held by company insiders. Comparatively, 40.2% of MEDIROM Healthcare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer CHGG or MRM? In the previous week, Chegg had 9 more articles in the media than MEDIROM Healthcare Technologies. MarketBeat recorded 11 mentions for Chegg and 2 mentions for MEDIROM Healthcare Technologies. MEDIROM Healthcare Technologies' average media sentiment score of 0.49 beat Chegg's score of 0.36 indicating that MEDIROM Healthcare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chegg 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral MEDIROM Healthcare Technologies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMEDIROM Healthcare Technologies beats Chegg on 9 of the 14 factors compared between the two stocks. Get MEDIROM Healthcare Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRM vs. The Competition Export to ExcelMetricMEDIROM Healthcare TechnologiesPersonal services IndustryMedical SectorNYSE ExchangeMarket Cap$78.35M$857.74M$5.52B$20.75BDividend YieldN/A2.11%4.60%3.66%P/E RatioN/A10.2330.0128.05Price / Sales0.0156.86450.0556.30Price / Cash1.4945.3736.7723.05Price / Book8.903.328.184.33Net Income$820K$39.59M$3.26B$994.32M7 Day Performance121.69%4.11%6.13%1.97%1 Month Performance97.99%3.26%0.07%-1.60%1 Year Performance-6.44%218.04%36.31%14.39% MEDIROM Healthcare Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRMMEDIROM Healthcare Technologies0.7757 of 5 stars$2.76+130.0%N/A-6.4%$78.35M$8.30B0.00480News CoverageShort Interest ↑Gap UpHigh Trading VolumeCHGGChegg3.6506 of 5 stars$1.40+10.7%$1.70+21.9%-45.7%$134.28M$617.57M-0.171,271HCMAHCM AcquisitionN/A$7.42+0.3%N/A-9.0%$104.93MN/A0.00N/AGap DownSTGSunlands Technology Group1.5639 of 5 stars$8.35+10.4%N/A-7.2%$102.20M$272.66M2.682,071News CoveragePositive NewsUpcoming EarningsShort Interest ↑Gap UpYSXTYSX TechN/A$3.12+4.3%N/AN/A$66.56MN/A0.0040NAMINAMIN/A$0.86-3.4%N/AN/A$60.85MN/A0.00N/ABEDUBright Scholar EducationN/A$1.73-0.3%N/A-7.8%$51.43M$247.56M-0.372,193KUKEKuke Music0.5239 of 5 stars$2.38+3.9%N/A-83.9%$46.54M$9.59M0.00170News CoverageGap DownAACGATA0.8716 of 5 stars$1.47+36.1%N/A+186.4%$34.46M$36.72M-10.50580News CoverageEarnings ReportHigh Trading VolumeKIDZClassoverN/A$1.33-8.0%N/AN/A$34.11MN/A0.00N/AGap UpFEDUFour Seasons Education (Cayman)N/A$14.54+4.3%N/A+17.8%$31.50M$34.48M0.00290Gap Down Related Companies and Tools Related Companies Chegg Competitors HCM Acquisition Competitors Sunlands Technology Group Competitors YSX Tech Competitors NAMI Competitors Bright Scholar Education Competitors Kuke Music Competitors ATA Competitors Classover Competitors Four Seasons Education (Cayman) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MRM) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEDIROM Healthcare Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEDIROM Healthcare Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
